| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Clapp Geoffrey, Chief Product Officer
Sold 774 shares ($28.2K) |
| 12 Nov 2026 |
Form 4: Anevski Peter, Director
Received 185,134 shares by exercise or conversion ($168K) · Sold 236,630 shares ($8.48M) |
| 12 Nov 2026 |
Form 4: Schlanger David J, Director
Received 35,392 shares by exercise or conversion ($32.2K) · Sold 35,392 shares ($1.25M) |
| 12 Nov 2026 | 144 |
| 10 Nov 2026 | 144 |
| 09 Nov 2026 |
Form 4: Anevski Peter, Director
Received 3,400 shares by exercise or conversion ($3.09K) · Sold 11,939 shares ($419K) · Received 126,204 shares by exercise or conversion ($115K) · 1 more |
| 09 Nov 2026 |
Form 4: Schlanger David J, Director
Received 3,400 shares by exercise or conversion ($3.09K) · Sold 3,400 shares ($120K) · Received 161,208 shares by exercise or conversion ($147K) · 1 more |
| 06 Nov 2026 |
Form 4: Livingston Mark S., CHIEF FINANCIAL OFFICER
Sold 2,139 shares ($64.2K) |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 04 Nov 2026 |
Form 4: Swartz Allison, EVP, GC
Received 8,160 shares as a grant or award · Granted 11,370 Stock Option (Right to Buy) |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net Income |
| 04 Nov 2026 | 144 |
| 27 Oct 2026 | SCHEDULE 13G/A |
| 16 Oct 2026 |
Form 4: Cummings Melissa B, Chief Operating Officer
Gave up 1,559 shares to cover exercise price or tax ($42.7K) · Sold 1,879 shares ($52.6K) |
| 14 Oct 2026 | 144 |
| 28 Sep 2026 |
Form 4: Swartz Allison, EVP, GC
Sold 3,903 shares ($102K) |
| 23 Sep 2026 | 144 |
Loading...